Alert detail

FDA Approval: ARIKAYCE (AMIKACIN) — Type 3 - New Dosage Form

Policy ID: FDA-NDA207356Specialty: PulmonologyAdded: 7/1/2026Effective: 2018-09-28billing update
High

Full alert analysis requires a subscription

Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.